Cargando…
Effect of Uric Acid-Lowering Agents on Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Background: Elevated serum uric acid (SUA) level is considered an independent predictor of all-cause mortality and the combined endpoint of death or readmission in cardiovascular disease patients. However, the causal relationship between uric acid-lowering therapies (ULTs) and heart failure is still...
Autores principales: | Xu, Hongxuan, Liu, Yunqing, Meng, Lingbing, Wang, Li, Liu, Deping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144321/ https://www.ncbi.nlm.nih.gov/pubmed/34046437 http://dx.doi.org/10.3389/fcvm.2021.639392 |
Ejemplares similares
-
U-Shaped Association Between Serum Uric Acid Level and Hypertensive Heart Failure: A Genetic Matching Case-Control Study
por: Xu, Hongxuan, et al.
Publicado: (2021) -
Paroxetine and Mortality in Heart Failure: A Retrospective Cohort Study
por: Xu, Hongxuan, et al.
Publicado: (2022) -
Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Ying, Hangying, et al.
Publicado: (2021) -
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Ying, Hangying, et al.
Publicado: (2021) -
Self-reported prevalence and potential factors influencing cardio-cerebral vascular disease among the Chinese elderly: A national cross-sectional study
por: Meng, Lingbing, et al.
Publicado: (2022)